EORTC AISBL / IVZW Avenue Mounierlaan, 83/11 Brussel 1200 Bruxelles • Belgie Belgique +32 2 774 16 11
Intranet • Home

Open studies are marked with a purple background, closed studies have a grey background, studies to be opened have a white background

10951	Randomized phase II and III study in first line hormonal treatment for metastatic breast cancer with Exemestane or Tamoxifen in postmenopausal patients
10031	A Phase III Trial Evaluating the Role of Ovarian Function Suppression and the Role of Exemestane as Adjuvant Therapies for Premenopausal Women with Endocrine Responsive Breast Cancer tamoxifen versus ovarian function suppression + tamoxifen versus ovarian function suppression + exemestane (SOFT).

Back to Protocol section